Brexpiprazole Impurity 131
✓
100% accuracy
of data
24/7 scientific
support
⬡
0% tolerance in
quality of product

Stock Locations

  • New Jersey, USA
  • Czech Republic, EU
  • Mumbai, India

* Stock subject to availability.

Documentation

Download MSDS

Download Sample COA

Includes: HPLC, MASS/LC-MS, 1H NMR, FT-IR, Potency, Structure Elucidation Report (SER), and additional analytical data depending on the product.

Brexpiprazole Impurity 131

● In Stock

Catalogue No.:VE0025322
CAS No.:N/A
Mol. Formula:C13H14INO2
Mol. Weight:343.16 g/mol

Additional information on Brexpiprazole Impurity 131

Parent drug

Brexpiprazole

IUPAC Name

7-(4-iodobutoxy)quinolin-2(1H)-one

Pharmacopoeial Synonyms

N/A

Other Synonyms

N/A

Smiles

O=C1NC2=CC(OCCCCI)=CC=C2C=C1

InChI

InChI=1S/C13H14INO2/c14-7-1-2-8-17-11-5-3-10-4-6-13(16)15-12(10)9-11/h3-6, 9H, 1-2, 7-8H2, (H, 15, 16)

Description

Brexpiprazole Impurity 131 is a process and degradation related variant observed during manufacture and stability studies of brexpiprazole. This impurity exhibits distinct chromatographic and mass spectral behavior enabling identification by HPLC with UV detection and LC-MS confirmation | while structural elucidation is supported by 1H NMR and 13C NMR. Physicochemical profiling indicates lower polarity relative to the parent API and a propensity to form under oxidative or basic stress. Quantitative monitoring and specification setting in line with ICH Q3A and Q3B are recommended to ensure product safety and efficacy | with control strategies including optimized purification | in process monitoring and validated analytical methods.

Request a Quote

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Products quotation
Name
Url